In mantle cell lymphoma (MCL) the MCL-International Prognostic Index (MIPI) is a better predictor of event-free and overall survival than International Prognostic Index (IPI) in patients receiving intensive 1st line treatment including ASCT

Forskningsoutput: TidskriftsbidragPublicerat konferensabstract

Standard

In mantle cell lymphoma (MCL) the MCL-International Prognostic Index (MIPI) is a better predictor of event-free and overall survival than International Prognostic Index (IPI) in patients receiving intensive 1st line treatment including ASCT. / Geisler, C.; Elonen, E.; Kolstad, A.; Laurell, A.; Sundstrom, C; Delabie, J.; Ehinger, Mats; Karjalainen-Lindsberg, M-L; Ralfkiaer, E.; Brown, P.

I: Haematologica-The Hematology Journal, Vol. 94, 2009, s. 0971.

Forskningsoutput: TidskriftsbidragPublicerat konferensabstract

Harvard

APA

CBE

MLA

Vancouver

Author

RIS

TY - JOUR

T1 - In mantle cell lymphoma (MCL) the MCL-International Prognostic Index (MIPI) is a better predictor of event-free and overall survival than International Prognostic Index (IPI) in patients receiving intensive 1st line treatment including ASCT

AU - Geisler, C.

AU - Elonen, E.

AU - Kolstad, A.

AU - Laurell, A.

AU - Sundstrom, C

AU - Delabie, J.

AU - Ehinger, Mats

AU - Karjalainen-Lindsberg, M-L

AU - Ralfkiaer, E.

AU - Brown, P.

N1 - The information about affiliations in this record was updated in December 2015. The record was previously connected to the following departments: Pathology, (Lund) (013030000)

PY - 2009

Y1 - 2009

M3 - Published meeting abstract

VL - 94

SP - 0971

JO - Haematologica-The Hematology Journal

T2 - Haematologica-The Hematology Journal

JF - Haematologica-The Hematology Journal

SN - 1592-8721

ER -